Showing results (1711-1720 of 1,842) with videos related to
Sort By:
Pageof 185
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohortJ Mazières, F Barlesi, T Filleron, et al.Journal of Psychiatric Research|March 2, 2018
Maternal immune activation induced by lipopolysaccharide triggers immune response in pregnant mother and fetus, and induces behavioral impairment in adult ratsLutiana Roque Simões, Gustavo Sangiogo, Michael Hikaru Tashiro, et al.Science (New York, N.Y.)|January 30, 1970
Laser ranging retro-reflector: continuing measurements and expected resultsC O Alley, R F Chang, D G Currie, et al.Bioresearch Open Access|April 8, 2020
Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic DrugsWalter H Moos, Douglas V Faller, Ioannis P Glavas, et al.Leukemia & Lymphoma|November 28, 2024
Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemiaNicholas J Short, Agnieszka Wierzbowska, Thomas Cluzeau, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 5, 2021
Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN)Floriane Jochum, Tamara De Rozario, Lise Lecointre, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2019
Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal MetastasesRonan Flippot, Pamela Biondani, Edouard Auclin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectivesJulien Mazières, Solange Peters, Benoit Lepage, et al.The Lancet. Haematology|June 2, 2024
Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding studyOlga Salamero, Antonieta Molero, José Antonio Pérez-Simón, et al.Journal of Clinical Medicine|August 6, 2020
Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN)Virginie Bund, Lise Lecointre, Michel Velten, et al.Pageof 185